Research Studies
Back to Results
Intermediate-size Expanded Access to ONC201 for Patients with H3 K27M-mutant and/or Midline Gliomas
Details
Age
Child to Adult
Phase
Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.
Type of Study
Treatment
Location
Childrens Hospital Colorado
Principal Investigator
Kathleen Dorris
Study ID
Protocol Number: 20-2681
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers